Although no aging studies have been conducted with GLP-1 in healthy aged animals, GLP-1 has attracted some excitement as a possible therapy for diseases of neuronal injury, including Alzheimer’s disease, stroke, Huntington’s disease, and Parkinson’s disease (Li et al. 2009, 2010; Martin et al. 2009). Here, GCG is linked to Parkinson disease.